These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8695348)

  • 1. Synthesis and secretion of transforming growth factor beta isoforms by primary cultures of human breast tumour fibroblasts in vitro and their modulation by tamoxifen.
    Benson JR; Wakefield LM; Baum M; Colletta AA
    Br J Cancer; 1996 Aug; 74(3):352-8. PubMed ID: 8695348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple forms of TGF-beta 1 in breast tissues: a biologically active form of the small latent complex of TGF-beta 1.
    Baillie R; Coombes RC; Smith J
    Eur J Cancer; 1996 Aug; 32A(9):1566-73. PubMed ID: 8911119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta secretion from primary breast cancer fibroblasts.
    van Roozendaal CE; Klijn JG; van Ooijen B; Claassen C; Eggermont AM; Henzen-Logmans SC; Foekens JA
    Mol Cell Endocrinol; 1995 Apr; 111(1):1-6. PubMed ID: 7649348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tamoxifen on transcriptional level of transforming growth factor beta (TGF-beta) isoforms 1 and 2 in tumor tissue during primary treatment of patients with breast cancer.
    Brandt S; Kopp A; Grage B; Knabbe C
    Anticancer Res; 2003; 23(1A):223-9. PubMed ID: 12680217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.
    Perry RR; Kang Y; Greaves BR
    Br J Cancer; 1995 Dec; 72(6):1441-6. PubMed ID: 8519657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of transforming growth factor beta expression and induction of apoptosis by tamoxifen in ER positive and ER negative breast cancer cells.
    Benson JR; Baum M
    Br J Cancer; 1996 Sep; 74(6):993-4. PubMed ID: 8826875
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.
    Butta A; MacLennan K; Flanders KC; Sacks NP; Smith I; McKinna A; Dowsett M; Wakefield LM; Sporn MB; Baum M
    Cancer Res; 1992 Aug; 52(15):4261-4. PubMed ID: 1322240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts.
    Colletta AA; Wakefield LM; Howell FV; van Roozendaal KE; Danielpour D; Ebbs SR; Sporn MB; Baum M
    Br J Cancer; 1990 Sep; 62(3):405-9. PubMed ID: 1698443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.
    Arteaga CL; Koli KM; Dugger TC; Clarke R
    J Natl Cancer Inst; 1999 Jan; 91(1):46-53. PubMed ID: 9890169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of transforming growth factor-alpha by tamoxifen in human breast cancer.
    Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1993 Jul; 72(1):131-6. PubMed ID: 8508397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of transforming growth factor-beta1 and tumour necrosis factor-alpha on cultured fibroblasts from skin fibroma as modulated by toremifene.
    Lilli C; Marinucci L; Bellocchio S; Ribatti D; Balducci C; Baroni T; Cagini L; Giustozzi G; Locci P
    Int J Cancer; 2002 Apr; 98(6):824-32. PubMed ID: 11948458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
    Kurebayashi J; Otsuki T; Yamamoto S; Kurosumi M; Nakata T; Akinaga S; Sonoo H
    Oncology; 1998 Dec; 55 Suppl 1():23-34. PubMed ID: 9852399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.
    Mc Ilroy M; Fleming FJ; Buggy Y; Hill AD; Young LS
    Endocr Relat Cancer; 2006 Dec; 13(4):1135-45. PubMed ID: 17158759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of transforming growth factor beta by the antiestrogens droloxifene, tamoxifen, and toremifene in MCF-7 cells.
    Knabbe C; Zugmaier G; Schmahl M; Dietel M; Lippman ME; Dickson RB
    Am J Clin Oncol; 1991; 14 Suppl 2():S15-20. PubMed ID: 1835818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of endocrine therapy on the levels of oestrogen and progesterone receptor and transforming growth factor-beta 1 in metastatic human breast cancer: an immunocytochemical study.
    Murray PA; Gomm J; Ricketts D; Powles T; Coombes RC
    Eur J Cancer; 1994; 30A(9):1218-22. PubMed ID: 7999402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and role of TGF beta production in breast cancer.
    Knabbe C; Kopp A; Hilgers W; Lang D; Müller V; Zugmaier G; Jonat W
    Ann N Y Acad Sci; 1996 Apr; 784():263-76. PubMed ID: 8651574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.
    Thompson AM; Kerr DJ; Steel CM
    Br J Cancer; 1991 Apr; 63(4):609-14. PubMed ID: 2021547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.